Mar 10, 2021 10:00 AM
Through the Syapse Learning Health Network™, Pfizer will Generate Insights to
“By using real-world data collected from the Syapse Learning Health Network, we are able to understand treatment patterns, disease progression and the overall treatment journey. These data are informing and enhancing our clinical studies,” explained
Real-world data holds tremendous potential for improving the way that cancer care is conceptualized. The Syapse Learning Health Network is a global precision oncology data sharing network aggregating data from across 25 states, 457 hospitals and over 1300 community oncologists. The network enables providers to share and learn from real-world clinical, molecular, treatment, and outcomes data. A recent example is a study co-authored by
“Through this partnership with Pfizer, we have the opportunity to unlock the potential of real-world data and its ability to truly advance care,” explains
About the Syapse Learning Health Network™
This international network of healthcare providers enables improved cancer care by sharing real-world data to support clinical decisions and by fostering collaborations among participants. Healthcare providers, including doctors and nurses, share and learn which cancer treatments produced the best real-world outcomes in clinically and molecularly similar patients. Researchers learn from real-world clinical, molecular, treatment and outcomes data. These collaborations are enabled by a secure platform of shared de-identified data that is standardized and normalized across the Learning Health Network and complies with all applicable federal and state data privacy protection regulations.
Ryan McKenna, Media & Engagement email@example.com